As Flu Outpaces COVID This Winter, Rapid Molecular Testing Takes on New Importance

This winter’s respiratory season looks different from what many expected. Flu has once again pulled ahead of COVID in infections and hospitalizations, and the two illnesses are starting to resemble each other in how severe they can be. For healthcare providers who rely on fast decisions at the point-of-care, this shift is not a small […]

March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care

March is National Colorectal Cancer Awareness Month, which makes it an important time to highlight both the ongoing public health challenge of colorectal cancer and the technologies that are helping reshape early detection and treatment. Despite being one of the most preventable and treatable cancers when caught early, the Colorectal Cancer Alliance (CCA) reminds us […]

Global IVD Growth: Stability, Shifting Markets, and the Road to 2030

The global in vitro diagnostic market continues to expand in both size and strategic importance. According to the 18th edition of Kalorama Information’s The Worldwide Market for In Vitro Diagnostic (IVD) Tests, the industry now represents a $113 billion global market, up from just under $100 billion only five years ago. That growth alone signals […]

Cell and Gene Therapy at a Turning Point

It is an exciting and dynamic time to be involved in the cell and gene therapy industry. Kalorama Information estimates the global cell and gene therapy market at approximately $16 billion in 2025, spanning key therapeutic areas such as oncology, neurology, musculoskeletal, dermatology, cardiology, and others. Kalorama projects double‑digit global market growth through 2030. “Kalorama […]

Sepsis Gap & Home Testing Growth: Interview with Kalorama Information’s Daniel Granderson

This special blog post is reprinted with permission from the Eye on IVD newsletter and features an interview with Kalorama Senior Editor Daniel Granderson, offering insights into the IVD market outlook for 2026. Before we shift attention to J.P. Morgan Healthcare this year, let’s get a sense of where we are in in vitro diagnostics […]

What Is the Size of the IVD Market in 2025?

According to Kalorama Information, the IVD market is $113 billion.  As Kalorama releases its 18th edition of the Worldwide Market for In Vitro Diagnostic Tests, the IVD market is experiencing moderate-level growth. These are the main factors that will shape markets right now in IVD. Some will drive growth and others will limit growth. Some […]

Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain 

Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  Arlington, VA — June 2025 — A new survey of 195 diagnostic imaging and clinical lab professionals reveals that tariff policy uncertainty is already changing how providers plan staffing, purchasing, and vendor relationships. The latest Beyond the Bench […]

4 Fascinating Facts About Cancer Diagnostics

Kalorama Information is proud to introduce our recent report, The World Market for Cancer Diagnostics, 2024-2029. This comprehensive analysis provides an authoritative overview of the global cancer in vitro diagnostics (IVD) market, highlighting key trends, market sizing, and growth opportunities. In this report, you’ll find an in-depth review of the cancer IVD market, enriched with expert […]

Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge

The global veterinary diagnostics market is set to experience a 6% compound annual growth rate (CAGR) over the next five years. This growth is driven by low barriers to market entry, a competitive landscape that allows for substantial advancements in various segments, a continued surge in pet ownership, and growing concerns over the emergence of […]

Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies 

The lab diagnostics industry is evolving at an unprecedented pace, driven by shifting regulations, decentralized testing growth, and rapid advancements in molecular and point-of-care technologies. Companies relying on outdated anecdotal insights or outdated data risk falling behind in a competitive landscape where market shifts and customer demands evolve in real time. “Custom Competitive Intelligence (CI) […]